Author details

Full Name

Mark W Youngblood

Affiliation

ORCID

Career Start Year

2013

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36847778	Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma.	Cancer Res	2023
35976058	Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.	Neuro Oncol	2023
37944590	Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.	Nat Med	2023
37847034	Surgical Outcome of Patients With Supratentorial Meningiomas Aged 80 Years or Older-Retrospective International Multicenter Study.		2023
37805627	Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.	Nat Commun	2023
37900579	Repeat Surgery for Vestibular Schwannomas: An Institutional Case Series.		2023
38066633	A novel BRAF::PTPRN2 fusion in meningioma: a case report.		2023
36711497	B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFÎ²-mediated Immunosuppression.	Res Sq	2023
36993741	Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.	Res Sq	2023
37164210	Validating the VS-5 Score for Predicting Outcomes After Vestibular Schwannoma Resection in an Institutional Cohort.	World Neurosurg	2023
34816425	Simulated driving in the epilepsy monitoring unit: Effects of seizure type, consciousness, and motor impairment.	Epilepsia	2022
36321282	Outcomes following stereotactic radiosurgery for foramen magnum meningiomas: a single-center experience and systematic review of the literature.	Neurosurg Focus	2022
36315366	Radiotherapy for meningiomas.	J Neurooncol	2022
36116353	Optimizing the patient handoff and progress note documentation efficiency in the EPIC EMR system within a neurosurgery residency: A quality improvement initiative.	Journal of Clinical Neuroscience	2022
36497370	Clinical Management of Supratentorial Non-Skull Base Meningiomas.	Cancers (Basel)	2022
34967924	Correction to: The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.	J Neurooncol	2022
34846640	The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.	J Neurooncol	2022
34993480	Ultrasound-mediated blood-brain barrier opening increases cell-free DNA in a time-dependent manner.	Neurooncol Adv	2021
33914067	Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.	Neuro Oncol	2021
34350560	Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.	J Neurooncol	2021
33223030	Role of Resection in Glioblastoma Management.	Neurosurg Clin N Am	2021
34707999	Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy.	Front Oncol	2021
32553282	Molecular genetics of meningiomas.	Handb Clin Neurol	2020
33276341	Clinical and genomic factors associated with seizures in meningiomas.	J Neurosurg	2020
32945858	Commentary: Lumbar Lateral Recess Decompression: 2-Dimensional Operative Video.	Operative Neurosurgery	2020
30578106	Mutations in Chromatin Modifier and Ephrin Signaling Genes in Vein of Galen Malformation.	Neuron	2019
29676392	Integrated genomic analyses of de novo pathways underlying atypical meningiomas.	Nat Commun	2018
29397575	Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.	Mol Genet Genomic Med	2018
29350590	Human genetics and molecular mechanisms of vein of Galen malformation.	J Neurosurg Pediatr	2018
28153049	Longitudinal analysis of treatment-induced genomic alterations in gliomas.	Genome Med	2017
28805815	AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.	Nat Neurosci	2017
28630369	<i>ALPK3</i> gene mutation in a patient with congenital cardiomyopathy and dysmorphic features.	Cold Spring Harb Mol Case Stud	2017
28195122	Integrated genomic analyses of de novo pathways underlying atypical meningiomas.	Nat Commun	2017
27548314	Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.	Nat Genet	2016
25562830	Rhythmic 3-4Hz discharge is insufficient to produce cortical BOLD fMRI decreases in generalized seizures.	NeuroImage	2015
24417694	Ictal spread of medial temporal lobe seizures with and without secondary generalization: an intracranial electroencephalography analysis.	Epilepsia	2014
23850575	Seizure localization using three-dimensional surface projections of intracranial EEG power.	Neuroimage	2013
22653695	Intracranial EEG surface renderings: new insights into normal and abnormal brain function.	Neuroscientist	2013